Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS
MYLAN LABS has sixty-five approved drugs.
There are nine tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209911-002 | Sep 14, 2018 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | |||||
| Mylan Labs Ltd | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 216589-002 | Dec 12, 2025 | AB | RX | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Mylan Labs Ltd | GLUCAGON | glucagon | INJECTABLE;INJECTION | 204468-001 | Dec 12, 2024 | AP | RX | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

